Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ensayo Fase II de Trasplante autólogo de Sangre periférica en Pacientes Con Mieloma múltiple Tras Acondicionamiento Con Busulfan Intravenoso y Melfalan

NCT00804947 is registered in ClinicalTrials.gov with Fundacion Para La Investigacion Hospital La Fe as lead sponsor.

NCT NCT00804947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00804947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ensayo Fase II de Trasplante autólogo de Sangre periférica en Pacientes Con Mieloma múltiple Tras Acondicionamiento Con Busulfan Intravenoso y Melfalan
Lead sponsor
Fundacion Para La Investigacion Hospital La Fe
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2005
Completion date
March 31, 2010
Enrollment
50 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma